Company / Book Value per Share
Tarsus Pharmaceuticals, Inc. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$8.955
FY2025
5-year range
$6.563 / $8.955
FY2021-FY2025
Trend
+36.4%
vs FY2024
Sector context
#64 of 209
Health Care
What the data says
At $8.955, Tarsus Pharmaceuticals, Inc.'s book value per share ranks #64 of 209 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 4 years of decline, reaching $8.955.
Based on SEC 10-K filings.
$8.955 in FY2025 with a 5-year CAGR of -19.7%.
Improved from $7.378 to $8.955 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- -19.7%
- 10-Year CAGR
- -
Sector benchmark
#64 of 209 in Health CareTop 31% of 209This company $8.955 Sector average $189.406
▼
-95.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -19.7%, indicating a declining trend.
- In FY2025, book value per share increased 36.4% year-over-year.
- Ranks #64 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.955 | +36.4% |
| FY2024 | $6.563 | -11.0% |
| FY2023 | $7.378 | -8.4% |
| FY2022 | $8.055 | -1.8% |
| FY2021 | $8.204 | -69.3% |
| FY2020 | $26.739 | +1152.1% |
| FY2019 | -$2.542 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026